BIBBINSTRUMENTS AB
NNGM:BIBB0.36
SEK
+0.01
(+1.69%)
ISIN
SE0010102095
Return %
Stock
S&P 500
1Y
-84.33
14.20
3Y
-74.10
81.12
5Y
-91.61
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Fredrik Nils Lindblad
- Full Time Employees
- 4
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Lund Sweden
- IPO Date
- Oct 27, 2017
- Website
- bibbinstruments.com
- Similar Companies
- Business
- BiBBInstruments AB is a Sweden-based medical device company that develops, manufactures, and commercializes electric-driven endoscopic biopsy instruments for cancer diagnostics. The company provides a proprietary motorized biopsy platform marketed under the EndoDrill brand, designed to obtain high-precision core tissue samples for early and accurate histological tumor evaluation. Its commercial product portfolio comprises EndoDrill GI, a motorized endoscopic ultrasound biopsy instrument engineered for sampling lesions throughout the gastrointestinal tract, pancreas, stomach, and liver; EndoDrill EBUS, an electric-driven biopsy instrument optimized for endobronchial ultrasound procedures to sample mediastinal lymph nodes and lung tissue; and EndoDrill URO, a specialized endoscopic instrument developed for tissue acquisition in the upper and lower urinary tract, including bladder cancer diagnostics. BiBBInstruments AB targets gastroenterologists, pulmonologists, urologists, surgical oncologists, hospital networks, and academic medical centers. In recent operational developments, the company secured CE mark certification under the European Union Medical Device Regulation for its complete EndoDrill product suite, received 510(k) clearance from the United States Food and Drug Administration, and transitioned from a clinical-stage development model to international commercialization. To accelerate market penetration, BiBBInstruments AB entered into distribution agreements with TaeWoong Medical USA for distribution across North America and with Palex Medical for commercial expansion in Europe, while expanding its global intellectual property portfolio with new patent allowances across Europe and Asia. BiBBInstruments AB was founded in 2013 and is headquartered in Lund, Sweden.